Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Ely Lilly
The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.
More From Health News Florida
More From NPR Health

Subscribe to Health News Florida newsletter

How racism leads to chronic health conditions among Black people and whether reparations could help resolve these disparities.
How guns can endanger kids' lives and futures.
We highlight the stories of Black Floridians seeking emotional healing and wellness.
How distribution of the COVID-19 vaccine exposes inequities in Florida’s health care system.
Each day in Florida about 100 kids are involuntarily committed for psychiatric exams under the Baker Act. That adds up to about 36,000 kids a year, and experts say something has to be done. We explore what happens when kids get committed.